Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 38.70
+2.90 (8.10%)
Sep 2, 2026, 5:24 PM IDT
Nextage Therapeutics Revenue
Nextage Therapeutics had revenue of 1.35M ILS in the half year ending June 30, 2025, with 730.67% growth. This brings the company's revenue in the last twelve months to 243.00K, down -89.14% year-over-year. In the year 2024, Nextage Therapeutics had annual revenue of 413.00K, down -52.85%.
Revenue (ttm)
243.00K
Revenue Growth
-89.14%
P/S Ratio
5.19
Revenue / Employee
81.03K
Employees
31
Market Cap
13.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 413.00K | -463.00K | -52.85% |
| Dec 31, 2023 | 876.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 91.00K | -100.00K | -52.36% |
| Dec 31, 2020 | 191.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 180.82M |
| Erika Carmel-Tech | 37.34M |
| Bio-View | 20.70M |
| Evogene | 4.94M |